SCHEMBL6180298

SCHEMBL6180298

CCc1cccc(OC(CC)(C(=O)O)C(=O)O)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
ALDH1A1 P00352 2/20 0.40
HIF1A Q16665 1/20 0.40
ATM Q13315 1/20 0.40
PPARA Q07869 1/20 0.39
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323219 0.81 GABRA1 (0.39) KMT2AALDH1A1PPARAKDM4EGABRA1
SCHEMBL7324343 0.81 CA12 (0.42) ALDH1A1HIF1APPARALMNAMAPT
SCHEMBL7323725 0.79 TSHR (0.41) KMT2AALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL464374 0.75 CA12 (0.54) KMT2AMEN1ALDH1A1HIF1ALMNA
SCHEMBL5576461 0.74 GABRA1 (0.41) KMT2AMEN1ALDH1A1HIF1AATM
SCHEMBL7329544 0.73 HSD17B10 (0.51) KMT2AMEN1ALDH1A1HIF1A
Ammonia Solution, Strong SCHEMBL7313508 0.73 CA12 (0.53) KMT2AMEN1ALDH1A1HIF1ALMNA
SCHEMBL5133638 0.73 PTPN1 (0.53) KMT2AMEN1ALDH1A1HIF1APPARA
SCHEMBL15676611 0.73 RIPK1 (0.43) ALDH1A1KDM4EL3MBTL1
SCHEMBL8408142 0.71 GABRA1 (0.50) ALDH1A1ATMMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841326-B1 Process for the preparation of pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2001-05-16 EP claimed
EP-0979822-B1 Process for the preparation of 2-carbamoyl-pyridines HOFFMANN LA ROCHE (CH) 2005-11-30 EP disclosed
EP-0897914-B1 Process for the preparation of 2,5-disubstitued pyridines HOFFMANN LA ROCHE (CH) 2004-05-26 EP disclosed
EP-0526708-B1 Sulfonamide, preparation and use thereof as medicine and intermediate HOFFMANN LA ROCHE (CH) 2000-10-18 EP disclosed
US-6103902-A Carbamoylation process HOFFMANN-LA ROCHE INC. (US) 2000-08-15 US disclosed
US-6080866-A A CHEMICAL INTERMEDIATES FOR ENDOTHELIN RECEPTOR ANTAGONISTS HOFFMANN-LA ROCHE INC. (US) 2000-06-27 US disclosed
EP-0979822-A1 Process for the preparation of 2-carbamoyl-pyridines F. HOFFMANN-LA ROCHE AG (CH) 2000-02-16 EP disclosed
EP-0897914-A1 Process for the preparation of 2,5-disubstitued pyridines F. HOFFMANN-LA ROCHE AG (CH) 1999-02-24 EP disclosed
EP-0526708-A1 Sulfonamide, preparation and use thereof as medicine and intermediate F. HOFFMANN-LA ROCHE AG (CH) 1993-02-10 EP disclosed